Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients

Tigecycline has in vitro activity against multidrug-resistant and extensively drug-resistant Acinetobacter baumannii (MDR/XDRAB), and may constitute an alternative therapy for treating pneumonia caused by MDR/XDRAB. The aim of this study was to compare the efficacy of tigecycline-based therapy with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Won-Young, Moon, Jae-Young, Huh, Jin Won, Choi, Sang-Ho, Lim, Chae-Man, Koh, Younsuck, Chong, Yong Pil, Hong, Sang-Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775052/
https://www.ncbi.nlm.nih.gov/pubmed/26934182
http://dx.doi.org/10.1371/journal.pone.0150642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775052/
https://www.ncbi.nlm.nih.gov/pubmed/26934182
http://dx.doi.org/10.1371/journal.pone.0150642

Ejemplares similares